Top Tweets for #WeeklyCheckup
Biotech IPO activity is recovering, but remains fragile. After the post-pandemic boom and years of policy and economic uncertainty, early 2026 has brought renewed investor interest, particularly in later-stage companies. #WeeklyCheckup
https://t.co/GFACGngRM6
Biotech IPO activity is recovering, with larger and more mature companies returning to public markets. But a wave of mega-tech IPOs could narrow the window for biomedical innovation. #WeeklyCheckup
https://t.co/GFACGngRM6
Weekly Checkup: 2026 Key Areas of Interest – Drug Pricing - Michael Baker #WeeklyCheckup
https://t.co/6VzlhFoWzK
The notion that Americans are broadly convinced to toss aside their vaccination regimes is simply unfounded. Any health policy built on a plank of reducing the use of vaccines is likely to run into real trouble. #WeeklyCheckup
https://t.co/x5MwUqh7WJ
Weekly Checkup: The Part D Redesign – A Tragedy in Three Acts - @djheakin #WeeklyCheckup
https://t.co/T1tYoBJ9Gs
Weekly Checkup: Price Controls Can’t Control Drug Prices - @jaywalkuh #WeeklyCheckup
https://t.co/sp2kZ3RPPN
Weekly Checkup: Ask Better Questions: Three Health Care Misconceptions - @LauraRHobbs #WeeklyCheckup
https://t.co/eG97o23pgJ
Please see my last @AAF #weeklycheckup on three health care misconceptions. #IRA #MedicarePartD #PBMs and #ERISA
https://t.co/NZwydC9m45
Reports of #Medicare's DME Competitive Bidding Program's (CBP) death may be greatly exaggerated. The #weeklycheckup @AAF explores recent legislation to address DME rates as outlook for future of the program is increasingly murky.
https://t.co/NvbAFM3t3W
Weekly Checkup: ERISA Is the Bulwark Against Single-Payer - @HammondOnHealth #WeeklyCheckup https://t.co/Sq1hiffm3A
Last week @HouseGOP and @HELPCmteDems held a hearing on prescription drug costs. Check out @AAF @HammondOnHealth #weeklycheckup to better understand the relationship between costs and patient outcomes.
https://t.co/yeqAOMsSmO
Check out @AAF @HammondOnHealth #Weeklycheckup on #ACA enrollment. Hammond points out that "ACA plans provide worse care options without being cheaper for many beneficiaries" and that commercial and MA plans have larger provider networks than ACA plans.
https://t.co/PoGwETJz1s
Check out @HammondOnHealth @AAF #WeeklyCheckup on #DrugShortages #FDA and #DEA Restrictive #manufacturer quotas stop patient's from receiving medications they need.
Medicine Deficit Disorder https://t.co/C48uh3N1D2
Medicaid’s New “Covered Outpatient Drug” Definition: Rebate Reform? - @LauraRHobbs #WeeklyCheckup
https://t.co/jbWPKRUOPX
A district court recently ruled on the HRSA's ability to define a qualifying patient for the 340B Drug Pricing Program. Let’s dive into what this development may mean for 340B. #WeeklyCheckup
https://t.co/rVV7yFIWEA
#340B requires Congressional action as @HammondOnHealth explains in the @AAF #weeklycheckup. Potentially, following a district Court ruling, the program could become the largest #federal drug program with little oversight or #transparency.
https://t.co/2mfMi9jaay
Weekly Checkup: Medicare Final Rule-ah Palooza - @HammondOnHealth #WeeklyCheckup
https://t.co/i0BLdVuh3v
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
240.2M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
109M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.3M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.6M followers
KATY PERRY
@katyperry
86.8M followers
Taylor Swift
@taylorswift13
80.6M followers
Lady Gaga
@ladygaga
72.2M followers
Kim Kardashian
@kimkardashian
69.4M followers
YouTube
@youtube
68.6M followers
Virat Kohli
@imvkohli
68.6M followers
Bill Gates
@billgates
63.4M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
61.1M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
59.9M followers